Chisato Shimanoe

1.2k total citations
62 papers, 467 citations indexed

About

Chisato Shimanoe is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Chisato Shimanoe has authored 62 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Epidemiology. Recurrent topics in Chisato Shimanoe's work include Scoliosis diagnosis and treatment (6 papers), Nutrition and Health in Aging (6 papers) and Connective tissue disorders research (5 papers). Chisato Shimanoe is often cited by papers focused on Scoliosis diagnosis and treatment (6 papers), Nutrition and Health in Aging (6 papers) and Connective tissue disorders research (5 papers). Chisato Shimanoe collaborates with scholars based in Japan, United States and Poland. Chisato Shimanoe's co-authors include Megumi Hara, Keitaro Tanaka, Yuichiro Nishida, Yasuki Higaki, Hinako Nanri, Mikako Horita, Koichi Shinchi, Yosuke Yamada, Masaaki Mawatari and Naoto Taguchi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Chisato Shimanoe

57 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chisato Shimanoe Japan 14 104 65 64 50 45 62 467
Michael Boivin United States 12 78 0.8× 33 0.5× 44 0.7× 46 0.9× 40 0.9× 38 494
Alba Malara Italy 11 104 1.0× 55 0.8× 53 0.8× 93 1.9× 25 0.6× 38 497
Andrea A. Conti Italy 15 62 0.6× 83 1.3× 92 1.4× 48 1.0× 38 0.8× 51 632
Matthew J. Belanger United States 11 92 0.9× 119 1.8× 65 1.0× 52 1.0× 85 1.9× 19 501
María Martínez‐Ferrán Spain 9 122 1.2× 40 0.6× 44 0.7× 30 0.6× 27 0.6× 17 579
Alyson K. Myers United States 15 75 0.7× 21 0.3× 45 0.7× 69 1.4× 69 1.5× 47 504
Vince Fazekas‐Pongor Hungary 17 168 1.6× 90 1.4× 29 0.5× 40 0.8× 33 0.7× 49 708
Rosanne J.H.C.G. Beijers Netherlands 13 210 2.0× 24 0.4× 65 1.0× 56 1.1× 32 0.7× 28 642
Bertrand Fougère France 15 187 1.8× 55 0.8× 56 0.9× 75 1.5× 25 0.6× 51 683
Michael Freedman United States 13 97 0.9× 32 0.5× 80 1.3× 68 1.4× 49 1.1× 28 665

Countries citing papers authored by Chisato Shimanoe

Since Specialization
Citations

This map shows the geographic impact of Chisato Shimanoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chisato Shimanoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chisato Shimanoe more than expected).

Fields of papers citing papers by Chisato Shimanoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chisato Shimanoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chisato Shimanoe. The network helps show where Chisato Shimanoe may publish in the future.

Co-authorship network of co-authors of Chisato Shimanoe

This figure shows the co-authorship network connecting the top 25 collaborators of Chisato Shimanoe. A scholar is included among the top collaborators of Chisato Shimanoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chisato Shimanoe. Chisato Shimanoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Kobayashi, Takaomi, Megumi Hara, Chisato Shimanoe, et al.. (2024). Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials. Journal of Bone and Mineral Metabolism. 42(5). 492–502. 7 indexed citations
5.
Nanri, Hinako, Megumi Hara, Yuichiro Nishida, et al.. (2024). Interaction between Habitual Green Tea and Coffee Consumption and ACTN3 Genotype in Association with Skeletal Muscle Mass and Strength in Middle-Aged and Older Adults. The Journal of Frailty & Aging. 13(3). 267–275. 3 indexed citations
6.
Shimanoe, Chisato, et al.. (2024). Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure. In Vivo. 38(4). 1841–1846.
7.
Kobayashi, Takaomi, Tadatsugu Morimoto, Chisato Shimanoe, et al.. (2023). Risk factors for progression of the severity of locomotive syndrome: A two-year longitudinal observational study. Journal of Orthopaedic Science. 29(2). 646–652. 6 indexed citations
8.
Yamada, Yosuke, Yuichiro Nishida, Megumi Hara, et al.. (2023). Association Between the Appendicular Extracellular-to-Intracellular Water Ratio and All-Cause Mortality: A 10-Year Longitudinal Study. The Journals of Gerontology Series A. 79(2). 5 indexed citations
9.
Mizoguchi, Yoshito, et al.. (2023). Risk of delirium with antiepileptic drug use: a study based on the Japanese Adverse Drug Event Report database. International Journal of Clinical Pharmacy. 45(5). 1260–1266. 4 indexed citations
10.
Kobayashi, Takaomi, Tadatsugu Morimoto, Chisato Shimanoe, et al.. (2023). Clinical characteristics of locomotive syndrome categorised by the 25-question Geriatric Locomotive Function Scale: a systematic review. BMJ Open. 13(5). e068645–e068645. 4 indexed citations
11.
Yasu, Takeo, et al.. (2023). Monitoring of blood levels in patients administered CYP3A4 inhibitor during the maintenance phase of venetoclax administration. International Journal of Clinical Pharmacology and Therapeutics. 62(1). 56–60.
12.
Saita, Tetsuya, et al.. (2023). Localization of Sites of Osimertinib Action in Rat Intestine, Skin, and Lung by Immunohistochemistry. ACTA HISTOCHEMICA ET CYTOCHEMICA. 56(6). 145–151. 1 indexed citations
13.
Yamada, Yosuke, Yuichiro Nishida, Megumi Hara, et al.. (2023). Dose-response relationship between daily step count and prevalence of sarcopenia: A cross-sectional study. Experimental Gerontology. 175. 112135–112135. 7 indexed citations
14.
Hayama, Tadashi, et al.. (2022). Liquid Chromatographic Determination of <i>o</i>-Phosphoethanolamine in Human Plasma Using Fluorescent Derivatization. Chemical and Pharmaceutical Bulletin. 71(1). 10–14. 1 indexed citations
15.
Hamada, Yohei, et al.. (2021). Is trimethoprim/sulfamethoxazole-associated increase in serum creatinine a pseudo-elevation or true nephrotoxicity?. Journal of Infection and Chemotherapy. 27(8). 1193–1197. 7 indexed citations
16.
Shimanoe, Chisato, Akiko Matsumoto, Megumi Hara, et al.. (2020). Perceived stress, depressive symptoms, and cortisol-to-cortisone ratio in spot urine in 6878 older adults. Psychoneuroendocrinology. 125. 105125–105125. 9 indexed citations
17.
Hara, Megumi, et al.. (2018). Case-Control Study of Rotavirus Vaccine Effectiveness Compared to Test-Negative Controls or Hospital Controls. Journal of Epidemiology. 29(8). 282–287. 7 indexed citations
18.
Hara, Megumi, Takeshi Tsugawa, Chisato Shimanoe, et al.. (2018). Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children. Vaccine. 36(34). 5187–5193. 24 indexed citations
19.
Hara, Megumi, et al.. (2015). Estimating rotavirus vaccine effectiveness in Japan using a screening method. Human Vaccines & Immunotherapeutics. 12(5). 1244–1249. 17 indexed citations
20.
Shimanoe, Chisato, et al.. (2011). How is Patients' Awareness of Health Literacy Problems Related to Their Utilization of Community Pharmacists' Counseling Services?. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 37(1). 1–12. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Boivin Breakdown of academic impact, for papers by Alba Malara Breakdown of academic impact, for papers by Andrea A. Conti Breakdown of academic impact, for papers by Matthew J. Belanger Breakdown of academic impact, for papers by María Martínez‐Ferrán Breakdown of academic impact, for papers by Alyson K. Myers Breakdown of academic impact, for papers by Vince Fazekas‐Pongor Breakdown of academic impact, for papers by Rosanne J.H.C.G. Beijers Breakdown of academic impact, for papers by Bertrand Fougère Breakdown of academic impact, for papers by Michael Freedman
Rankless by CCL
2026